Further supporting the idea that a combined treatment is the best choice to address cancer cachexia, the association between exercise and EPO reduces circulating IL-6, even though such effect is lost when exercise starts long before tumor injection, likely due to an adaptation to the exercise protocol in the absence of a reinforcement in running speed and time. The gene discussed is EPO; the disease is neoplasm.